{"DataElement":{"publicId":"2183417","version":"1","preferredName":"Person Surgical Procedure Injury Eligibility Determination Ind-2","preferredDefinition":"the yes/no indicator whether a patient has had a major surgical procedure, open biopsy, or traumatic injury within 28 days of entry.","longName":"PER_SX_INJ_ELIG_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2744526","version":"1","preferredName":"Person Surgical Procedure Injury Eligibility Determination","preferredDefinition":"information related to the act of determining if a subject is suitable for enrollment in a study by having had a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue or damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","longName":"PER_SX_INJ_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2744524","version":"1","preferredName":"Surgical Procedure Wound Eligibility Determination","preferredDefinition":"Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which \"transplantation\" is used.:Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C15329:C3671:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Injury","conceptCode":"C3671","definition":"Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B9FB235-6AB9-2E95-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-24","modifiedBy":"ONEDATA","dateModified":"2008-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B9FD923-00A8-365A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"10000430","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000429","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104905","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000346","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000345","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104907","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"10000693","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"4104931","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"10000692","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104938","version":"1","longName":"GOG-0254","context":"NRG"}]}],"AlternateNames":[{"name":"PER_SX_INJ_ELIG_IND","type":"USED_BY","context":"CTEP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"PER_SX_INJ_ELIG_IND","type":"USED_BY","context":"COG"},{"name":"PER_SX_INJ_ELIG_IND","type":"USED_BY","context":"NRG"},{"name":"PER_SX_INJ_ELIG_IND","type":"USED_BY","context":"Alliance"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"PER_SX_INJ_ELIG_IND_X1","type":"OID, COG","context":"COG"}],"ReferenceDocuments":[{"name":"Has the patient had a major s","type":"Preferred Question Text","description":"Has the patient had a major surgical procedure, open biopsy or significant traumatic injury within 28 days of entry, or is there anticipation of a need for major surgical procedure during the course of the study?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to the first date of Bevacizumab therapy?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Has the patient had surgery (including open biopsy) within 4 weeks prior to anticipated first dose of bevacizumab (allowing for the fact that bevacizumab can be omitted from first cycle of chemotherapy)? ","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure, open biopsy, or significant traumatic injury within the past 28 days?","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Major surgical procedures, open biopsy or significant traumatic injury <=28 days prior to randomization or anticipation of need for elective or planned major surgical procedure during the course of the study","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Has the patient undergone a major surgical procedure, open biopsy or incurred a significant traumatic injury within 28 days prior to the first date of study therapy?","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 28 days prior to the first date of treatment on this study?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Major surgical procedure, open biopsy, or significant traumatic injury <=28 days prior to registration or anticipation of need for major surgical procedure during the course of the study","url":null,"context":"CTEP"},{"name":"COG_CRF_text_2","type":"Alternate Question Text","description":"Has the patient had major surgical procedure, laparoscopic procedure, open biopsy or significant traumatic injury within the indicated period","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Has the patient had, or anticipate to have, any of the following invasive procedures: major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to the first date of dalantercept therapy?","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure or significant traumatic injury?","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Has the patient had major surgery within 3 months of the first dose of cabozantinib, if there were no wound healing complications, or within 6 months of the first dose of cabozantinib, if there were wound complications?","url":null,"context":"CTEP"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Has the patient had any major surgeries or significant traumatic injury within 28 days prior to study entry?","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure, or significant traumatic injury within 28 days of treatment start date?","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Has patient had major surgery within 10 days of the first day of study drug dosing, and minor surgery within 7 days of the first day of study drug dosing?","url":null,"context":"CTEP"},{"name":"CRF Text14","type":"Alternate Question Text","description":"History of major surgery","url":null,"context":"CTEP"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure or significant traumatic injury within 28 days prior to the first date of treatment on this study?","url":null,"context":"NRG"},{"name":"NRG_CRF Text 3","type":"Alternate Question Text","description":"Has the patient undergone major surgery, excluding diagnostic biopsy, within 30 days (to allow for full recovery) prior to registration","url":null,"context":"NRG"},{"name":"NRG_CRF Text 2","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure, open biopsy or significant traumatic injury within 28 days of treatment start date of Bevacizumab therapy (cycle 2)?","url":null,"context":"NRG"},{"name":"CRF Text17","type":"Alternate Question Text","description":"Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to step 2 registration (with the exception of the craniotomy for surgical resection)","url":null,"context":"NRG"},{"name":"Theradex Question","type":"Alternate Question Text","description":"Has patient had any major surgical procedure, open biopsy, or significant traumatic injury less than 3 weeks or minor surgical procedures (e.g., core biopsy or fine needle aspiration) within 1 week from first dose of first study drug administration?","url":null,"context":"Theradex"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Prior major surgical procedure, open biopsy, or significant traumatic injury","url":null,"context":"CTEP"},{"name":"CRF Text 18","type":"Alternate Question Text","description":"Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to registration (with the exception of the craniotomy for surgical resection)","url":null,"context":"NRG"},{"name":"COG_CRF_TEXT_3","type":"Alternate Question Text","description":"Has the patient had or is planning to have any of the indicated invasive procedures within the specified time frames","url":null,"context":"COG"},{"name":"NRG_CRF text 4","type":"Alternate Question Text","description":"Will the patient have a major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to starting cediranib?","url":null,"context":"NRG"},{"name":"CRF Text19","type":"Alternate Question Text","description":"Has the patient had surgery within 7 days of registration?","url":null,"context":"Alliance"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Is patient being enrolled within 36 days of definitive diagnostic surgery?","url":null,"context":"COG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Did patient have or plan to have invasive procedures?","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Did patient have significant traumatic injury within 28 days prior to enrollment?","url":null,"context":"COG"},{"name":"CRF Text 20","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 28 days prior to the anticipated Cycle 1, Day 1","url":null,"context":"CTEP"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does the patient have a known need for a major surgical procedure  within 14 days of starting Ribociclib and Everolimus?","url":null,"context":"PBTC"},{"name":"CRF Text 21","type":"Alternate Question Text","description":"Have at least 4 weeks elapsed since surgery prior to registration?","url":null,"context":"CTEP"},{"name":"CRF Text 22","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 2 weeks prior to the anticipated start date of study treatment?","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Is the patient being enrolled and projected to begin protocol therapy no later than 36 days after definitive diagnostic surgery?","url":null,"context":"COG"},{"name":"ABTC 1701 Text 1","type":"Alternate Question Text","description":"Has the patient had major surgery (excluding skin biopsies and procedures for insertion of central venous access devices) within 4 weeks prior to start?","url":null,"context":"ABTC"},{"name":"CRF Text 23","type":"Alternate Question Text","description":"Did the patient have a major surgical procedure within 21 days prior to registration or anticipation of need for major surgical procedure during the course of study treatment?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 4 weeks prior to the anticipated start date of study treatment?","url":null,"context":"NRG"},{"name":"COG CRF Text 001","type":"Alternate Question Text","description":"Is the patient being enrolled and is protocol therapy projected to begin within 31 days of definitive diagnostic surgery?","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Has patient had major surgical procedure, other than for diagnosis, within 4 weeks prior to study enrollment, or the anticipation of the need for a major surgical procedure during the study?","url":null,"context":"COG"},{"name":"NRG_CRF_Text_5","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 28 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Has the patient undergone any major surgical procedures within 30 days prior to registration?","url":null,"context":"NRG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"Did the patient have diagnostic surgery for GBM within 7 weeks prior to registration?","url":null,"context":"ECOG-ACRIN"},{"name":"NRG_CRF_Text_6","type":"Alternate Question Text","description":"Has the patient had a major surgical procedure within 28 days prior to registration, or anticipation of need for major surgical procedure during the study?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D90CBB28-101A-6C17-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-27","modifiedBy":"TYRRELLM","dateModified":"2023-12-20","changeDescription":"Replaced VD Therapy Ind-2 2018279v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"12.20.2023 Added AQT per request ticket CADSR0003202_mmt\r\n2/14/23 added AQT for NRG ticket number CADSR0002048 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}